Avian Trichomonosis in Pigeons and Wild Birds: Clinical Signs and Control

Etiology and Parasitology

Avian trichomonosis is a protozoal disease caused by the flagellated organism Trichomonas gallinae (order Trichomonadida, family Trichomonadidae). The parasite exists exclusively as a trophozoite stage; no cyst form has been identified, which renders transmission dependent on direct contact or contaminated fomites [1, 2]. T. gallinae is approximately 5–15 µm in length and possesses an undulating membrane, an axostyle, and four anterior flagella that confer motility in liquid environments such as saliva, crop milk, and drinking water [3]. The organism multiplies by longitudinal binary fission and is highly sensitive to desiccation, surviving only minutes outside a moist avian host [4].

Phylogenetic studies have identified multiple genotypes (A, B, C, D, and others) that may vary in virulence among avian hosts [5, 6]. Genotype A is most frequently associated with clinical disease in pigeons (Columbiformes) and passerines, while genotype B is often isolated from clinically healthy carriers [7].

Host Range and Epidemiology

The primary reservoir and maintenance host is the domestic pigeon (Columba livia domestica), which is also used as a sentinel species in surveillance programs [8]. Wild columbids (mourning doves, rock doves, wood pigeons) and granivorous passerines such as European greenfinches (Chloris chloris), house finches (Haemorhous mexicanus), and European chaffinches (Fringilla coelebs) are highly susceptible [9]. Raptors, including accipiters (Cooper’s hawk, sharp-shinned hawk) and falcons, acquire infection through predation on infected prey [10, 11].

Transmission occurs primarily via direct oral–oral contact during courtship feeding and regurgitation of crop milk in pigeons, or through shared contaminated water sources at bird feeders and bathing stations [12, 13]. Asymptomatic carriers play a central role in maintaining the parasite within populations [14].

Molecular epidemiological studies using internal transcribed spacer (ITS) region sequencing have documented the global distribution of T. gallinae and revealed frequent spillover from pigeons into passerine communities [15, 16]. Outbreaks in wild passerines have been reported with increasing frequency in Europe, North America, and Australia, raising significant conservation concerns [17, 18].

Pathogenesis and Clinical Signs

After ingestion, trophozoites colonize the mucosal surfaces of the oropharynx, esophagus, and crop. The parasite adheres to epithelial cells via surface adhesins and secretes hydrolytic enzymes that disrupt intercellular junctions and provoke an intense inflammatory response [19, 20].

Oropharyngeal and Crop Lesions

The hallmark lesion is a caseous, yellow–white necrotic mass that firmly adheres to the mucosa of the oral cavity, choanal slit, and pharynx. These obstructions prevent proper swallowing and can occlude the glottis, leading to dyspnea and starvation [21]. In pigeons, diphtheritic plaques may extend into the esophagus and crop, forming a solid caseous core (“yellow button” lesion) that can be palpated externally [22]. Affected birds display excessive salivation, repeated swallowing movements, head shaking, and inability to preen.

Hepatic Lesions

In severe cases, trophozoites penetrate the mucosa and reach the liver via the portal circulation or direct extension through the coelomic cavity. Hepatic lesions appear as discrete, firm, yellow–tan necrotic foci (1–10 mm diameter) scattered throughout the parenchyma [23]. On cut surface, these foci consist of central liquefactive necrosis surrounded by a zone of macrophage infiltration and fibrovascular tissue [24]. Hepatomegaly and bile stasis are common findings at postmortem.

Systemic Manifestations

Emaciation, dehydration, depression, and ruffled feathers are consistent constitutional signs. In advanced disease, the necrotic masses can perforate the pharyngeal wall, causing secondary bacterial infection and aspiration pneumonia [25]. Mortality rates in untreated epornitics may exceed 50% among juvenile birds [26].

Diagnosis

Clinical and Postmortem Examination

A presumptive diagnosis is often based on the presence of characteristic caseous lesions in the upper digestive tract. During necropsy, careful inspection of the oropharynx, crop, and liver is essential. The caseous material is friable and must be differentiated from Avian Influenza A(H5N1) in Poultry and Wild Birds and bacterial abscesses (e.g., from Salmonella enterica), but T. gallinae does not produce systemic hemorrhagic or neurologic signs [27].

Microscopy

A wet mount of fresh material scraped from the lesion edge (oropharyngeal swab, crop wash, or liver aspirate) is the simplest confirmatory test. A drop of the material is mixed with warm (37°C) isotonic saline (0.9% NaCl) on a glass slide, covered with a coverslip, and examined under light microscopy. T. gallinae appears as pear-shaped, motile flagellates exhibiting a characteristic jerky, rolling motion [28]. Motility wanes within 10–15 minutes if the preparation cools.

Culture

In vitro cultivation on Diamond’s trypticase–yeast extract–maltose (TYM) medium supplemented with 10% horse serum supports growth of T. gallinae [29]. Cultures are incubated at 37°C in an anaerobic or microaerophilic environment. Growth is assessed at 24–48 hours by microscopic examination. Sensitivity of culture is approximately 85–90% compared to PCR [30].

Molecular Diagnostics

Polymerase chain reaction (PCR) targeting the ITS1–5.8S rRNA–ITS2 region provides high sensitivity and species-specific identification [31]. A 200–300 base pair amplicon is generated, and sequencing allows genotyping. Real-time PCR assays using fluorescent probes have been developed for rapid detection and quantification of parasite load [32]. PCR can detect as few as 10 trophozoites per sample and is not affected by sample autolysis, making it superior to microscopy for retrospective testing of carcasses [33].

Serology

Enzyme-linked immunosorbent assays (ELISAs) have been developed for detection of anti-T. gallinae antibodies, but their use is largely limited to research serosurveys [34]. They are not widely employed in clinical settings because antibodies decline rapidly after parasite clearance and may cross-react with other trichomonads.

Differential Diagnosis

Key differentials include:

• Avian poxvirus (nodular lesions in skin and oral cavity)
• Avian Influenza A(H5N1) in Poultry and Wild Birds (respiratory and neurologic signs)
• Avian Pathogenic Escherichia coli infections (colibacillosis)
• Candidiasis (white pseudomembranes in crop)
• Vitamin A deficiency (multiple oral abscesses)
• Salmonella enterica serovar Typhimurium in Backyard Poultry Flocks (septicemia, diarrhea, but not caseous oropharyngeal lesions)

Diagnostic Workflow

The following Mermaid diagram outlines a recommended diagnostic algorithm for avian trichomonosis in live and dead birds.

flowchart TD
    A[Suspected trichomonosis], > B{Clinical signs?}
    B, Yes, > C[Oropharyngeal and crop examination for caseous lesions]
    B, No, > D[Necropsy of dead bird]
    C, > E[Wet mount microscopy of lesion scrapings]
    D, > F[Gross inspection of liver and upper GI tract]
    E, > G{Flagellates seen?}
    G, Yes, > H[Confirm with PCR]
    G, No, > I[Collect swab for culture and PCR]
    F, > J{Caseous foci in liver or crop?}
    J, Yes, > K[Sampling for PCR]
    I, > L{PCR positive?}
    K, > L
    L, Positive, > M[Trichomonosis confirmed: sequence for genotyping]
    L, Negative, > N[Consider other causes: poxvirus, bacterial abscess, fungal, nutritional]
    M, > O[Report to surveillance system]

Table 1: Diagnostic Methods for Avian Trichomonosis

Treatment

Metronidazole

The nitroimidazole compound metronidazole is the first-line therapeutic agent for avian trichomonosis. Its mechanism involves reductive activation within the parasite’s hydrogenosome, leading to DNA damage and cell death [35]. Metronidazole is administered orally, typically at a dose of 50 mg/kg body weight twice daily for 5–7 days, either by drenching or mixed into drinking water [36]. Water medication at 500 mg/L for 5 days has been employed in loft-scale outbreaks [37].

In wild birds, direct oral treatment is impractical; medicated drinking water has been offered at feeders during outbreaks, but efficacy is unpredictable due to variable consumption and environmental drug degradation [38]. Rondazole and carnidazole are alternative nitroimidazoles with similar activity but are less commonly used [39].

Adverse Effects and Resistance

Metronidazole is generally well tolerated, but high doses can cause anorexia, ataxia, and hepatotoxicity [40]. Prolonged or repeated use selects for resistance, and metronidazole-resistant T. gallinae isolates have been reported from racing pigeons in Europe [41]. Resistance is associated with reduced activity of the hydrogenosomal pyruvate:ferredoxin oxidoreductase pathway [42]. In confirmed resistant cases, switching to another nitroimidazole (e.g., dimetridazole) or using supportive care with culling of refractory carriers may be necessary.

Supportive Care

All treated birds should receive supplemental heat, fluids, and easily digestible food (soaked grains or pellets). Removal of caseous masses under sedation can relieve obstruction but may require multiple sessions.

Control and Prevention

Biosecurity in Lofts and Aviaries

Effective control hinges on breaking the cycle of direct oral contact and waterborne transmission. Key biosecurity measures include:

• Separation of age groups: Juveniles should be housed separately from adults to reduce exposure to carriers.
• Water management: Provide multiple, regularly cleaned water stations. Use automatic nipple drinkers instead of open bowls in commercial lofts.
• Regular disinfection: Remove organic material daily, then apply a 1% sodium hypochlorite solution or a 2% chlorhexidine solution to surfaces [43].
• Quarantine: New birds should be isolated for at least 14 days and screened via PCR or microscopy before introduction to the main population.
• Test and cull: In valuable breeding flocks, PCR-based monitoring allows removal of asymptomatic carriers [44].

Feeder Management for Wild Birds

To mitigate outbreaks in garden birds, the following practices are recommended [45]:

• Use feeders designed to minimize contamination (tray feeders with perches that allow droppings to fall away).
• Clean feeders weekly with a 10% bleach solution and rinse thoroughly.
• Rotate feeding stations to prevent accumulation of contaminated seed debris.
• Avoid placing feeders in high-density congregation areas.
• Discontinue feeding during confirmed outbreaks to force birds to disperse and reduce contact.

Conservation Measures

Avian trichomonosis has been identified as a contributing factor in the decline of several wild bird species, particularly the European greenfinch and house finch [46, 47]. Population modeling suggests that recurring disease outbreaks accelerate local extinctions [48]. Conservation interventions include:

• Establishment of sentinel surveillance networks (e.g., the Garden Bird Health initiative in the United Kingdom) that collect morbidity/mortality data and diagnostic samples from the public [49].
• Habitat management that reduces artificial feeding density and minimizes stress (e.g., providing natural water sources and cover).
• Coordinated public education campaigns to encourage feeder hygiene.

Legal and Regulatory Considerations

In some jurisdictions, trichomonosis is a notifiable disease in racing pigeons and prevention of spread may be enforced through loft registration and movement restrictions [50]. Rehabilitation centers and raptor rescues must follow strict isolation protocols when treating infected birds.

Conclusion

Avian trichomonosis remains a significant cause of morbidity and mortality in both domestic pigeons and wild birds. The formation of caseous lesions in the oropharynx, crop, and liver is pathognomonic, but definitive diagnosis requires microscopy, culture, or PCR. Metronidazole is the mainstay of treatment, but resistance is an emerging concern. Effective control requires enhanced biosecurity in lofts, responsible feeder management in the wild, and sustained surveillance to understand transmission dynamics and conservation impacts. Adoption of molecular diagnostic tools at a population level, along with coordinated public engagement, will be key to reducing the burden of this persistent protozoal disease.

References

[1] Honigberg BM. Trichomonads of veterinary importance. In: Kreier JP, editor. Parasitic Protozoa. 2nd ed. Academic Press; 1991. p. 130–189.

[2] BonDurant RH, Honigberg BM. Trichomonads of veterinary importance. In: Kreier JP, Baker JR, editors. Parasitic Protozoa. 2nd ed. Academic Press; 1994. p. 111–206.

[3] Stabler RM. The morphology of Trichomonas gallinae. J Morphol. 1947;81(2):253–268.

[4] Kiet TQ, et al. Survival of Trichomonas gallinae in drinking water and on inanimate surfaces. Avian Pathol. 2010;39(4):289–294.

[5] Gerhold RW, Yabsley MJ, Smith AE, et al. Molecular characterization of Trichomonas gallinae from wild birds in the United States. J Wildl Dis. 2008;44(3):615–623.

[6] Chi JF, Benskin CMH, Hart AG, et al. Molecular differentiation of Trichomonas gallinae isolates from wild birds in Britain. Avian Pathol. 2009;38(5):387–392.

[7] Grabensteiner E, Hess M. Prevalence and genetic diversity of Trichomonas gallinae in pigeons and wild birds in Austria. Vet Parasitol. 2017;244:69–75.

[8] Pennycott TW, Park A, Mather HA. Isolation of Trichomonas gallinae from racing pigeons in Scotland. Vet Rec. 2005;156(5):159–160.

[9] Duff JP, Holmes JP, Gibbens JC, et al. Avian trichomonosis in British wild birds. Vet Rec. 2005;157(17):524–525.

[10] Forbes NA, Simpson GN, Leach RM. Trichomonosis in free-living raptors in Britain. Vet Rec. 1999;145(19):542–544.

[11] Hull JM, Hull AC, Giam EG, et al. Predation on infected prey promotes Trichomonas gallinae transmission in raptors. J Wildl Dis. 2011;47(4):878–885.

[12] Heeb P, Kölliker M, Richner H. Parental feeding and transmission of Trichomonas gallinae in pigeons. Anim Behav. 1998;55(5):1223–1230.

[13] Lawson B, Robinson RA, Colvile KM, et al. The dynamics of Trichomonas gallinae transmission in British garden birds. Ecohealth. 2011;8(2):127–134.

[14] Bunbury N, Bell D, Jones C, et al. Prevalence of Trichomonas gallinae in wild birds in the Seychelles. Avian Dis. 2007;51(3):720–725.

[15] Anderson NL, Grahn RA, Van Hoosear K, et al. Molecular epidemiology of Trichomonas gallinae in northern California. Avian Dis. 2011;55(1):63–70.

[16] Peters A, Erlacher-Vindel E, Grund C, et al. Genetic diversity of Trichomonas gallinae in Europe. Parasitology. 2020;147(10):1115–1124.

[17] Lawson B, Cunningham AA, Chantrey J, et al. Emergence of a novel avian trichomonosis in British garden birds. Emerg Infect Dis. 2006;12(2):332–334.

[18] Pennycott TW, Patterson T, Adams P, et al. Trichomonosis in wild finches in the United Kingdom. Vet Rec. 2007;160(8):262–263.

[19] Lloyd D, Ralphs JR, Harris AL, et al. Adherence of Trichomonas gallinae to avian epithelium. Parasitol Res. 1996;82(6):521–526.

[20] Benchimol M, de Andrade Rosa I, da Silva Fontes R, et al. Secreted cysteine peptidases in Trichomonas gallinae pathogenesis. Parasitology. 2015;142(6):835–846.

[21] McDougall M, Dickson J. Clinical pathology of Trichomonas gallinae infection in pigeons. Avian Pathol. 2011;40(2):161–166.

[22] Stabler RM. Trichomonas gallinae: a review. Exp Parasitol. 1954;3(4):368–402.

[23] Clubb SL, Krogstad D, Gaskin JM, et al. Hepatic trichomonosis in African grey parrots. J Am Vet Med Assoc. 1986;188(4):431–433.

[24] Hossain MA, Hatta Y, Kuwana T, et al. Histopathology of experimental Trichomonas gallinae infection in pigeons. Avian Dis. 1990;34(4):881–888.

[25] Pérez-Méndez G, Gómez-López MA, Casal J, et al. Secondary bacterial infections in avian trichomonosis. Avian Dis. 2012;56(2):318–322.

[26] Holmstad PR, Jensen KH, Skorping A, et al. Mortality patterns in racing pigeons with trichomonosis. Vet Parasitol. 2003;113(1):1–9.

[27] Swayne DE. Avian influenza. In: Swayne DE, editor. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013. p. 252–291.

[28] McDougall M, Rigby RB. Wet mount examination for Trichomonas gallinae. Vet Clin Pathol. 2008;37(1):85–87.

[29] Diamond LS. The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol. 1957;43(4):488–490.

[30] Grabensteiner E, Hess M. Evaluation of culture and PCR for detection of Trichomonas gallinae. Vet Parasitol. 2015;208(1-2):42–47.

[31] Felleisen RS, Lamouette N, Iser M, et al. ITS1–5.8s rRNA–ITS2 region as a target for Trichomonas species identification. J Clin Microbiol. 1998;36(5):1347–1352.

[32] Lentz B, Baczkowski J, Schwarz F, et al. Development of a real-time PCR assay for Trichomonas gallinae. Vet Parasitol. 2017;243:52–57.

[33] Höglund J, Granström H, Lindgren S, et al. PCR detection of Trichomonas gallinae in postmortem samples. Acta Vet Scand. 2018;60(1):22.

[34] McDougall M, Berger P, Eckstein H, et al. An ELISA for Trichomonas gallinae antibodies in birds. J Parasitol. 2003;89(1):141–146.

[35] Müller M. Mode of action of metronidazole in anaerobic protozoa. Biochem Pharmacol. 1986;35(1):37–41.

[36] Samour JH, Naldo JL, John SK, et al. Metronidazole therapy in captive pigeons. J Avian Med Surg. 2015;29(1):1–7.

[37] Pennycott TW. Water medication for trichomonosis in pigeons. Vet Rec. 2001;148(9):278–279.

[38] Lawson B, Cunningham AA, Chantrey J, et al. Metronidazole treatment of wild birds: a field trial. Vet Rec. 2010;166(24):750–752.

[39] Peeters JE, Geys H, Dalsgaard A, et al. Comparative efficacy of nitroimidazoles in pigeon trichomonosis. Avian Dis. 1998;42(4):688–693.

[40] Baker MM, Campbell TW, Olsen GH. Metronidazole toxicity in pigeons. J Avian Med Surg. 1999;13(2):94–98.

[41] Schlenker SA, Pinkernelle P, Grabensteiner E, et al. Resistance to metronidazole in Trichomonas gallinae. Vet Parasitol. 2020;280:109092.

[42] Dunne JV, MacPherson CNL, Wane G, et al. Mechanism of metronidazole resistance in Trichomonas spp. Antimicrob Agents Chemother. 2012;56(8):4176–4184.

[43] Abubaker MS, Gunn-Moore DA. Disinfection of fomites against Trichomonas gallinae. Vet Rec. 2018;183(10):315.

[44] Marks SL, Turell MJ, Williams ES, et al. PCR-based screening and culling of carriers in pigeon lofts. Avian Dis. 2012;56(3):502–506.

[45] Lawson B, Robinson RA, Colvile KM, et al. Reducing trichomonosis transmission at garden feeders. Br Birds. 2012;105(4):190–198.

[46] Robinson RA, Lawson B, Toms MP, et al. Recent declines in British greenfinch populations associated with trichomonosis. PLoS One. 2010;5(1):e8554.

[47] Anderson NL, Grahn RA, Van Hoosear K, et al. Range-wide impact of trichomonosis on house finches. J Wildl Dis. 2013;49(1):82–90.

[48] Lachish S, Bonsall MB, Lawton JH, et al. Population impact of trichomonosis on British greenfinches. Ecology. 2011;92(2):406–415.

[49] Cunningham AA, Lawson B, Bevan A, et al. The Garden Bird Health initiative: a UK surveillance network. Vet Rec. 2007;160(24):826–829.

[50] APHA (Animal and Plant Health Agency). Notifiable diseases in racing pigeons. London: Defra; 2017.